The 7 linked references in paper A. Komarov L., А. Комаров Л. (2016) “ДЛИТЕЛЬНАЯ АНТИКОАГУЛЯНТНАЯ ТЕРАПИЯ ПРИ ВТОРИЧНОЙ ПРОФИЛАКТИКЕ ОСТРОГО КОРОНАРНОГО СИНДРОМА: КАК ВЫБРАТЬ БОЛЬНОГО? // LONG-TERM ANTICOAGULATION THERAPY IN SECONDARY PREVENTION OF ACUTE CORONARY SYNDROME: HOW TO CHOOSE THE PATIENT?” / spz:neicon:aterotromboz:y:2016:i:1:p:26-38

  1. 2014 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal, doi:10.1093/eurheartj/ehu278. (the paper at Socionet)
  2. 2013 ACCF/AHA Guideline for the Management of STElevation Myocardial Infarction. JACC,2013, 61(4): e78140.
  3. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal, 2012, 33: 2569-2619. doi:10.1093/eurheartj/ehs215.
  4. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal, 2016, 37: 267-315. doi:10.1093/eurheartj/ehv320. (the paper at Socionet)
  5. http://www.crusadebleedingscore.org.
  6. Karve AM, Seth M, Sharma M. Contemporary Use of Ticagrelor in Interventional Practice (from Blue Cross Blue Shield of Michigan Cardiovascular Consortium). Am J Cardiol, 2015 Jun 1, 115(11): 1502-6. doi: 10.1016/j.amjcard.2015.02.049.
  7. Gandhi S, Zile B, Tan MK. Increased Uptake of Guideline Recommended Oral Antiplatelet Therapy: Insights from the Canadian Acute Coronary Syndrome Reflective. Canadian Journal of Cardiology, 2014. doi: 10.1016/j.cjca.2014.09.011.